epigallocatechin gallate has been researched along with Arrhythmias, Cardiac in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, YY; Fu, LX; Gan, RZ; Li, L; Liang, G; Lv, MX; Zhang, XX; Zhou, H; Zhou, JL; Zhu, HQ | 1 |
Bao, L; Bu, H; Chen, H; Chen, X; Lu, F; Min, Q; Song, Y; Sun, H; Zhao, B | 1 |
3 other study(ies) available for epigallocatechin gallate and Arrhythmias, Cardiac
Article | Year |
---|---|
The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
Topics: Alcohol Oxidoreductases; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Carcinoma, Hepatocellular; Cardiotoxicity; Catechin; Cell Proliferation; Daunorubicin; Drug Synergism; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Heart Rate; Hep G2 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
High concentration of epigallocatechin-3-gallate increased the incidences of arrhythmia and diastolic dysfunction via β2-adrenoceptor.
Topics: Animals; Arrhythmias, Cardiac; Camellia sinensis; Catechin; Glucose; Heart; Male; Muscle Contraction; Myocardium; Myocytes, Cardiac; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Tea; Tromethamine | 2015 |
More benefits for green tea drinkers?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catechin; Contraindications; Humans; Tea | 2004 |